A Case of Advanced Thymic Carcinoma with Diffuse Liver Metastases and Acute Liver Failure Treated with a Combination of Carboplatin and Paclitaxel-Reference-Cited by-同舟云学术

A Case of Advanced Thymic Carcinoma with Diffuse Liver Metastases and Acute Liver Failure Treated with a Combination of Carboplatin and Paclitaxel

Published:2022-08-20 Issue:4 Volume:62 Page:335-340
ISSN:0386-9628
Container-title:Haigan
language:en
Short-container-title:JJLC

Author:

Iwasaki Kazuhiko¹,Hara Johsuke¹,Watanabe Satoshi¹,Tambo Yuichi¹,Ohkura Noriyuki¹,Sone Takashi¹,Kimura Hideharu¹,Saito Daisuke²,Kasahara Kazuo¹,Yano Seiji¹

Affiliation:

1. Department of Respiratory Medicine, Kanazawa University Hospital

2. Department of Respiratory Surgery, Kanazawa University Hospital

Publisher

Japan Lung Cancer Society

Subject

Pulmonary and Respiratory Medicine,Oncology

Link

https://www.jstage.jst.go.jp/article/haigan/62/4/62_335/_pdf

Reference15 articles.

1. 1. Gatta G, van der Zwan JM, Casali PG, Siesling S, Dei Tos AP, Kunkler I, et al. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer. 2011; 47: 2493-2511.

2. 2. Hishida T, Nomura S, Yano M, Asamura A, Yamashita M, Ohde Y, et al. Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study. Eur J Cardiothorac Surg. 2016; 49: 835-841.

3. 3. Sato J, Satouchi M, Itoh S, Okuma Y, Niho S, Mizugaki H, et al. Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial. Lancet Oncol. 2020; 21: 843-850.

4. 4. Okuma Y, Ko R, Shukuya T, Tateishi K, Imai H, Iwasawa S, et al. Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapy. Lung Cancer. 2020; 148: 122-128.

5. 5. Lemma GL, Lee JW, Aisner SC, Langer CJ, Tester WJ, Johnson DH, et al. Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma. J Clin Oncol. 2011; 29: 2060-2065.